No black box warning on record for Rasagiline Mesylate

As of the latest FDA labeling reviewed, Rasagiline Mesylate (RASAGILINE MESYLATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Rasagiline Mesylate medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS May cause hypertension (including severe hypertensive syndromes) at recommended doses ( 5.1 ) May cause serotonin syndrome when used with antidepressants ( 5.2 ) May cause falling asleep during activities of daily living, daytime drowsiness, and somnolence ( 5.3 ) May cause hypotension, especially orthostatic ( 5.6 ) May cause or exacerbate dyskinesia. Decreasing the lev

No black box warning on record for Rasagiline Mesylate

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS May cause hypertension (including severe hypertensive syndromes) at recommended doses ( 5.1 ) May cause serotonin syndrome when used with antidepressants ( 5.2 ) May cause falling asleep during activities of daily living, daytime drowsiness, and somnolence ( 5.3 ) May cause hypotension, especially orthostatic ( 5.6 ) May cause or exacerbate dyskinesia. Decreasing the lev

Rasagiline Mesylate Black Box Warning

No black box warning on record for Rasagiline Mesylate

Other warnings & precautions

Rasagiline Mesylate Black Box Warning

No black box warning on record for Rasagiline Mesylate

Other warnings & precautions